MIR3926-1

Across TCGA pan-cancer cohorts, MIR3926-1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR3926-1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR3926-1 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR3926-1 is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

BRCA, LUSC, and BLCA are the cancer types where MIR3926-1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3926-1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	−0.355	<.001	8	view →
LUSC	Male	III,IV	−0.972	.010	2	view →
BLCA	Male	All	+0.499	.029	2	view →
COAD	All	II,III,IV	−0.150	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR3926-1–BRCA

Open the BRCA breakdown →